Drug Intervention in Chronic Fatigue Syndrome - No Study Results Posted

Drug Intervention in Chronic Fatigue Syndrome (KTS-1-2008)

This study has been completed.

Study NCT00848692 Information provided by Haukeland University Hospital

First Received: February 19, 2009 Last Updated: June 1, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	June 2010
Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)

No publications provided by Haukeland University Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Fluge Ø, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H, Mella O. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS One. 2011;6(10):e26358. Epub 2011 Oct 19.